US Broker Ratings

Tandem Diabetes Care (TNDM) Investor Outlook: Navigating a 6.66% Upside in the Medical Devices Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the medical devices industry, continues to capture the attention of investors with its innovative solutions for diabetes management. With a..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 62% Potential Upside Amid Analyst Optimism

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, operates a robust network of surgical facilities across the United States. The company, headquartered in Brentwood, Tennessee, provides..

PACS Group, Inc. (PACS) Stock Analysis: A Robust 31% Revenue Growth Sets Stage for 15% Potential Upside

PACS Group, Inc. (PACS), a key player in the healthcare sector, has been turning heads with its impressive performance and promising outlook. Operating primarily in the medical care facilities industry,..

UFP Technologies, Inc. (UFPT) Stock Analysis: 43% Potential Upside Sparks Investor Interest

UFP Technologies, Inc. (NASDAQ: UFPT) stands out in the healthcare sector, particularly within the medical devices industry, not just for its innovative product solutions but also for its compelling investment..

Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling a 77.57% Potential Upside in the Biotech Sector

Immunocore Holdings plc (NASDAQ: IMCR), a leading name in the biotechnology sector, has captured the attention of investors with its innovative approach to developing immunotherapies for cancer and infectious diseases...

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A Biotech Pioneer with 37.8% Potential Upside

For investors looking to tap into the lucrative biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a compelling opportunity. With a market capitalization of $3.21 billion, Apellis is a promising..

Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings Highlight 23% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a key player in the biotechnology sector, has captured the attention of investors with its robust revenue growth and a promising pipeline of biopharmaceutical assets...

Concentra Group Holdings (CON): A Healthcare Stock with 44% Upside Potential and Strong Buy Ratings

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector, is capturing investor attention with its strong growth prospects and favorable analyst ratings. Based in Addison, Texas,..

ImmunityBio, Inc. (IBRX) Stock Analysis: Biotechnology Innovator with a 358% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with a remarkable potential upside of 358.15%, according to recent analyst ratings. As a dynamic player in the biotechnology sector,..

Alvotech (ALVO) Stock Analysis: Unpacking the 348% Potential Upside

Alvotech (NASDAQ: ALVO), a burgeoning player in the healthcare sector, is making waves with its focus on developing and manufacturing biosimilar medicines. Based in Luxembourg, Alvotech is positioned within the..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Potential 48% Upside in the Biotech Sector

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a rising star within the biotechnology industry, recently captured investor attention with its promising growth trajectory and substantial upside potential. With a market capitalization of..

Privia Health Group, Inc. (PRVA) Stock Analysis: 30% Potential Upside Ignites Investor Interest

Privia Health Group, Inc. (NASDAQ: PRVA) is capturing the attention of investors with its impressive 30.15% potential upside, presenting a compelling opportunity in the healthcare sector. As a national leader..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a Promising 9% Upside in the Fertility Solutions Space

Progyny, Inc. (NASDAQ: PGNY), a specialized healthcare plans provider, is making waves in the U.S. market with its innovative approach to fertility and family-building benefits. With a market capitalization of..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 9.2% Potential Upside with Strong Buy Ratings

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a key player in the healthcare sector, is making waves with its diverse portfolio of generic and specialty pharmaceuticals. With a market capitalization of $4.03..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Investors Eye a 27% Upside Potential in Biotech Innovation

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has captured the attention of investors seeking opportunities in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $4.19 billion, this..

Merus N.V. (MRUS) Stock Analysis: A Close Look at Its Flat Performance and Growth Prospects

Merus N.V. (NASDAQ: MRUS), a biotechnology firm based in the Netherlands, is navigating the complex waters of the healthcare sector with a focus on antibody therapeutics, particularly for oncology indications...

Arcellx, Inc. (ACLX) Stock Analysis: Unveiling a 72% Potential Upside in Biotech Innovation

Arcellx, Inc. (NASDAQ: ACLX) is capturing the attention of investors with its promising advancements in biotechnology. Specializing in the development of cutting-edge immunotherapies for cancer and other incurable diseases, Arcellx..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a Potential 26.36% Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare space, particularly in the medical devices industry, is capturing the attention of investors with its robust array of diagnostic solutions...

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Promising Biotech with an 18.84% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention in the biotechnology sector, offering promising growth potential with an impressive 18.84% upside. As a commercial-stage pharmaceutical company, Harmony focuses..

Clover Health Investments (CLOV): Assessing Its 24% Potential Upside and Revenue Growth Prospects

Clover Health Investments, Corp. (NASDAQ: CLOV) continues to intrigue investors with its innovative approach to healthcare plans, particularly in the Medicare Advantage space. Based in Wilmington, Delaware, the company is..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds